0
Researchers have achieved a significant breakthrough by elucidating the structure of amyloid beta bound to glycolipids on the surface of nerve cells. This finding shed light on the critical role of abnormal amyloid beta fibril formation, a major contributor to Alzheimer’s disease, and holds promise for innovative advancements in medicine and pharmacy.